Humana Inc.
HUM
$262.12
-$0.66-0.25%
| Weiss Ratings | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | C | |||
| Rating Factors | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.36 | |||
| Price History | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.10% | |||
| 30-Day Total Return | -8.00% | |||
| 60-Day Total Return | -7.07% | |||
| 90-Day Total Return | 1.70% | |||
| Year to Date Total Return | 3.75% | |||
| 1-Year Total Return | -21.82% | |||
| 2-Year Total Return | -46.48% | |||
| 3-Year Total Return | -37.01% | |||
| 5-Year Total Return | -25.75% | |||
| 52-Week High % Change | -35.51% | |||
| 52-Week Low % Change | 22.88% | |||
| Price | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $406.46 | |||
| 52-Week Low Price | $213.31 | |||
| 52-Week Low Price (Date) | Oct 02, 2024 | |||
| 52-Week High Price (Date) | Jul 18, 2024 | |||
| Valuation | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 31.62B | |||
| Enterprise Value | 42.12B | |||
| Price/Earnings (TTM) | 26.33 | |||
| Earnings Per Share (TTM) | 9.95 | |||
| Earnings Per Share Growth | -49.79% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.27 | |||
| Price/Book (Q) | 1.93 | |||
| Enterprise Value/Revenue (TTM) | 0.36 | |||
| Price | $262.12 | |||
| Enterprise Value/EBITDA (TTM) | 10.50 | |||
| Enterprise Value/EBIT | 13.84 | |||
| Market Cap Category | Large Cap | |||
| Dividends and Shares | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 120.46M | |||
| Dividend Yield | 1.35% | |||
| Div. Per Share (Most Recent) | $0.89 | |||
| Dividend Per Share (TTM) | $3.54 | |||
| Payout Ratio (TTM) | 35.71% | |||
| Dividend Per Share (Most Recent) | $0.89 | |||
| Company Info | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 502 580 1000 | |||
| Address | Humana Building Louisville, KY 40202 | |||
| Website | www.humana.com | |||
| Country | United States | |||
| Year Founded | 1961 | |||
| Profitability | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 2.58% | |||
| Profit Margin | 1.02% | |||
| Management Effectiveness | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 4.07% | |||
| Return on Equity | 7.41% | |||
| Income Statement | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 113.31B | |||
| Total Revenue (TTM) | 117.76B | |||
| Revenue Per Share | $977.63 | |||
| Gross Profit (TTM) | 17.10B | |||
| EBITDA (TTM) | 4.01B | |||
| EBIT (TTM) | 3.04B | |||
| Net Income (TTM) | 1.21B | |||
| Net Income Avl. to Common (TTM) | 1.21B | |||
| Total Revenue Growth (Q YOY) | 10.40% | |||
| Earnings Growth (Q YOY) | -26.48% | |||
| EPS Diluted (TTM) | 9.95 | |||
| EPS Diluted Growth (Q YOY) | -30.47% | |||
| Balance Sheet | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 20.44B | |||
| Cash Per Share (Q) | $169.65 | |||
| Total Current Assets (Q) | 29.82B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.45B | |||
| Current Ratio (Q) | 1.760 | |||
| Book Value Per Share (Q) | $135.73 | |||
| Total Assets (Q) | 46.48B | |||
| Total Current Liabilities (Q) | 16.94B | |||
| Total Debt (Q) | 12.65B | |||
| Total Liabilities (Q) | 30.03B | |||
| Total Common Equity (Q) | 16.38B | |||
| Cash Flow | HUM - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -2.95B | |||
| Cash from Financing (TTM) | -2.49B | |||
| Net Change in Cash (TTM) | -2.47B | |||
| Levered Free Cash Flow (TTM) | -1.42B | |||
| Cash from Operations (TTM) | 2.97B | |||
